| CLASS | CHAL | LP7784-4 |
| COMPONENT | Pyridoxine^post 250 mg pyridoxine PO | LP306743-8 |
| PROPERTY | SCnc | LP6860-3 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Qn | LP7753-9 |
| parent | Pyridoxine | Serum or Plasma | Chemistry - challenge | LP387171-4 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Observation | |
| EXAMPLE_UNITS | nmol/L | |
| EXAMPLE_UCUM_UNITS | nmol/L | |
| UNITSREQUIRED | Y | |
| STATUS | ACTIVE |
| LONG_COMMON_NAME | en-US | Pyridoxine [Moles/volume] in Serum or Plasma --post 250 mg pyridoxine PO |
| LONG_COMMON_NAME | en-US | Pyridoxine [Moles/volume] in Serum or Plasma --post 250 mg pyridoxine PO |
| SHORTNAME | en-US | Vit B6 p 250 mg Vit B6 PO SerPl-sCnc |
| ConsumerName | en-US | Pyridoxine after 250 mg Pyridoxine by mouth, Blood |
| SHORTNAME | es-AR | piridoxina^después de 250 mg de piridoxina vía oral:concentración de sustancia:punto en el tiempo:suero/plasma:cuantitativo: |
| SHORTNAME | pt-BR | Vit B6 p 250 mg Vit B6 PO SerPl-sCnc |
| LONG_COMMON_NAME | fr-FR | Pyridoxine après pyridoxine (250mg,PO) [Moles/Volume] Sérum/Plasma ; Numérique |
| LONG_COMMON_NAME | nl-NL | Pyridoxine^na 250 mg pyridoxine PO [mol/volume] in serum of plasma |
| LONG_COMMON_NAME | es-MX | Piridoxina : Suero o Plasma : Punto temporal: Concentración de sustancias: Cuantitativo: |
LOINC Version: 2.81
FHIR